A $NOVN Investor!

“Vision, Courage & Patience” = Success

[A $NOVN Investor! @ixshares]

$NOVN what a tragic end of the @Novan_Biotech story! As an investor, lost my lifetime savings.I've taken this experience as a reminder of the importance of self due diligence, diversification and risk management.
Never trust & follow someone @InCausaPro you don’t know!

[A $NOVN Investor! @ixshares]

$NOVN investors, anyone considering legal action against @Novan_Biotech management and BODs ?

[A $NOVN Investor! @ixshares]

$NOVN any buyer now at $10M market valuation?

[A $NOVN Investor! @ixshares]

@Jim_Rothman @Cryptoman77064 @chiones_d $NOVN up 9% after hours!

[A $NOVN Investor! @ixshares]

$NOVN has $25+ M of intangible assets and a lead candidate SB206 under approval. Current market cap of $19M is not at all justifiable!

[A $NOVN Investor! @ixshares]

@Jeff84604803 @chiones_d @vanjohn10 Is there a way to blacklist such analysts and companies involved in heavy investor losses?

[A $NOVN Investor! @ixshares]

@Jeff84604803 @chiones_d That will be unfortunate and then investigations should start on involved private equity, analysts and parties involved in the background for this outcome.

[A $NOVN Investor! @ixshares]

@chiones_d $NOVN less than $14M market cap now and more selling going on. With $25+ M intangible assets on balance sheet, possibility of term loans and NDA in process.Why it’s getting hammered?

[A $NOVN Investor! @ixshares]

$NOVN

[A $NOVN Investor! @ixshares]

$NOVN block buying in action!

[A $NOVN Investor! @ixshares]

$NOVN & $VRCA both developing for #molluscum contagiosum. @Novan_Biotech at $19M market capitalization and @VerricaPharma at $251M !

[A $NOVN Investor! @ixshares]

$NOVN respectable market cap is atleast $200M! 10 times of current stock price.

[A $NOVN Investor! @ixshares]

$NOVN Mr.James L. Bierman, BOD https://t.co/MIKLr97NXH. Bierman’s decision was based on a decision to pursue other commercial opportunities & not based on any disagreement regarding its operations, policies or practices of ⁦@Novan_Biotech⁩
https://t.co/TmAWL4ys8l

[A $NOVN Investor! @ixshares]

$NOVN Nasdaq hits 52 weeks high. Is tech still the sector to own or funds will soon start to flow to undervalued companies like @Novan_Biotech ?

[A $NOVN Investor! @ixshares]

$NOVN A fatal mistake, as will become clear in the future. Novan's product pipeline is now home to an intrinsic value in the billions. SB206 and SB204 alone have the potential to fill a multi-billion dollar market sector, with SB206, a niche market.

[A $NOVN Investor! @ixshares]

$NOVN

-Novan has a product pipeline with product candidates in phase 2 studies and one product candidate in phase 3 studies.

-Novan got sales force through the acquisition of Epi Health and is generating revenue through the sale of already acquired, approved products.

[A $NOVN Investor! @ixshares]

$NOVN Facts - A comparison between Verrica and Novan reveals the totally unrealistic representation of Novan's market capital.

[A $NOVN Investor! @ixshares]

$NOVN facts

A company that filed an NDA to treat a disease that does not yet have an FDA approved drug and has a global market value of around $2B to $2.5B will have a market cap of Traded $20M? And that's just part of the intrinsic value of Novan Inc.

[A $NOVN Investor! @ixshares]

$NOVN facts

The NITRICIL platform technology offers a wide range of potential applications. Epi Health with its concluded agreements and its product range is at this time worth more than Novan Inc's current market capital.

[A $NOVN Investor! @ixshares]

@TrendWatchAU @Khaleda46247189 @Novan_Biotech Hope so! They should clarify otherwise It will feel like last 3 days saleoff was insider trading.

[A $NOVN Investor! @ixshares]

$NOVN John M. Gay CFO reports proposed sale of securities.Seriously at this price ! https://t.co/V0NHodlRRf